Question 1

What is SciSparc?

Accepted Answer

SciSparc is a Company.

Question 2

How often does SciSparc appear in global news?

Accepted Answer

Tracked across 3 news events drawn from 18 articles.

Question 3

When was SciSparc first tracked by Ergen?

Accepted Answer

First tracked on May 28, 2026.

Question 4

When was SciSparc last mentioned in news?

Accepted Answer

Last active on Jul 29, 2026.

Question 5

What is SciSparc's current news sentiment?

Accepted Answer

Aggregate sentiment score: 28 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is SciSparc in global news coverage?

Accepted Answer

Attention score of 4, derived from article volume and coverage intensity across 3 events.

Question 7

What is the most recent event involving SciSparc?

Accepted Answer

NeuroThera Labs acquires CliniQuantum Ltd. (May 28, 2026, 6 articles).

Question 8

How did the "NeuroThera Labs acquires CliniQuantum Ltd." event impact SciSparc?

Accepted Answer

SciSparc, through its majority-owned subsidiary NeuroThera Labs Inc., is expanding its portfolio into quantum simulation for clinical trials by acquiring a controlling interest in CliniQuantum

Question 9

How did the "NeuroThera initiates Phase IIb Tourette trial" event impact SciSparc?

Accepted Answer

SciSparc is the parent company of NeuroThera and stands to benefit from positive trial outcomes. The announcement may improve its stock sentiment.

Question 10

How did the "NeuroThera validates quantum workflow" event impact SciSparc?

Accepted Answer

SciSparc announced the validation, which supports its strategy of broadening exposure beyond drug development into computational technologies.

Question 11

How is this data collected?

Accepted Answer

Ergen aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.